Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor.
about
Brain-specific angiogenesis inhibitor-1 signaling, regulation, and enrichment in the postsynaptic densityThe cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteinsG-protein coupled receptor BAI3 promotes myoblast fusion in vertebrates.A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysisEmerging Roles of BAI Adhesion-GPCRs in Synapse Development and PlasticityEpidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis markerThe BAI subfamily of adhesion GPCRs: synaptic regulation and beyondAnti-angiogenic gene therapy in the treatment of malignant gliomasPhagocytosis of apoptotic cells in homeostasisType IV collagen is an activating ligand for the adhesion G protein-coupled receptor GPR126GPR126 protein regulates developmental and pathological angiogenesis through modulation of VEGFR2 receptor signalingInternational Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptorsProteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin alpha(v)beta3 to glycosaminoglycansSticky signaling--adhesion class G protein-coupled receptors take the stageOrgan-specific function of adhesion G protein-coupled receptor GPR126 is domain-dependentAdhesion GPCRs as Modulators of Immune Cell Function.Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis.Brain-specific angiogenesis inhibitor-1 expression in astrocytes and neurons: implications for its dual function as an apoptotic engulfment receptor.BAI1 regulates spatial learning and synaptic plasticity in the hippocampusVasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1.Adhesion GPCRs in Tumorigenesis.Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1.Herpes simplex virus oncolytic therapy for pediatric malignanciesHistidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatinNovel functional complexity of polycystin-1 by GPS cleavage in vivo: role in polycystic kidney diseaseDefective p53 antiangiogenic signaling in glioblastoma.Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth.Disease-associated mutations affect GPR56 protein trafficking and cell surface expression.Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer.Genome-wide detection and analysis of hippocampus core promoters using DeepCAGE.TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1α activity.Defining the gene repertoire and spatiotemporal expression profiles of adhesion G protein-coupled receptors in zebrafish.Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy.Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virusP14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancerExtracellular matrix protein CCN1 limits oncolytic efficacy in glioma.Post splenectomy related pulmonary hypertension.
P2860
Q24295603-5403BFFA-7D85-4EC2-95A2-FE4C17689A10Q24338193-D24AEF9A-A914-42F9-873F-6C04BD1BB32FQ24338272-3168DAFF-7720-4367-A58C-80EB6A15C281Q24602445-387BB79A-E171-44C1-A7DB-986CB84EE0A5Q26765596-13694527-C527-4A30-AC87-2E3EB99C0803Q26771513-951510BB-82DF-413B-A294-6D6FA53E9F2DQ26864858-1205CF2D-59F6-4767-9468-63883DB7E2CBQ26866276-F7F699A3-DBE2-4154-8EE3-233C4B12B09DQ28081044-F6DA2AED-BFD4-49EE-8EDF-5BCA6D6AAB02Q28245840-DBA45DB2-62F1-4ABD-8455-F5AF8BBBB2D1Q28247820-85F8EDE5-4668-41C3-8599-F6E144372CC2Q28257710-AD0612AB-4372-4E85-B402-ECE259AA064CQ28264269-03EFE65A-9B4E-4997-B181-EF0FCD02B3D0Q28291130-21F2EA71-01AE-4680-8CC8-C1978D648C5AQ28299560-E135F60C-74C3-4E4D-8A6C-EB2F72DD3FBAQ30275444-10930B0A-D47C-4866-8131-A64C0F5AC716Q30276066-C92A092E-00D0-4B99-B29C-B36844DF7F32Q30426156-00830551-E8DB-4978-BF99-28290409215BQ33112266-7DD0E1CE-AD04-47D4-9B80-BEC0A3E421EEQ33112684-03E015DA-6D30-4284-822F-0EB13A1CD641Q33112696-865521A7-5592-4162-9327-3B05AB17A659Q33558191-5B36500B-CD23-42F0-A613-B0A6FB2C1CA6Q33638847-685CA269-F1CE-4D03-AB41-A77C517D92AEQ33713824-130E18B3-846B-4729-807A-A8A059FDC5F4Q33745306-DDA050FB-68CB-46CF-AB57-D6B8F0976C9BQ34056378-396A6000-0AB3-4CA4-A72F-65B3FF0C382DQ34133118-BEDBB3A8-3003-4C32-8F16-3F76D015E30DQ34341736-6BFBF476-2E97-4FDA-A66C-1F8F7E76A72AQ34638842-427F68EE-43D8-494E-B1F8-80A3A1663779Q34715771-A167B3C9-68E5-491C-97DE-E9DAD0E0CECAQ34901415-D12F7E04-09D2-4CC9-A9EE-07F6C5FECC61Q34926095-B53993F8-2F5A-4AB8-9DDC-0D56D2A2C6AAQ35104663-B6AB1058-1EAE-4ECA-9B0D-5E6882A6F194Q35119552-35F40D36-5199-4553-936D-CB5659F6999BQ35190706-D9B4599A-8E89-409E-8EBC-BD8CFA238CDAQ35750059-15AFC39B-23D1-4186-A952-617EC5F12F22Q35858003-DA08FB7E-3469-4B82-A673-785071B87F5AQ35908448-41896307-D639-43E6-9DAA-A6DB54E09224Q36004674-A6AA6A0F-6F3A-4CE4-8486-B51A056AD65EQ36653460-0031AE99-D0FE-4B44-970F-489FADB4585E
P2860
Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Vasculostatin, a proteolytic f ...... ic and antitumorigenic factor.
@ast
Vasculostatin, a proteolytic f ...... ic and antitumorigenic factor.
@en
type
label
Vasculostatin, a proteolytic f ...... ic and antitumorigenic factor.
@ast
Vasculostatin, a proteolytic f ...... ic and antitumorigenic factor.
@en
prefLabel
Vasculostatin, a proteolytic f ...... ic and antitumorigenic factor.
@ast
Vasculostatin, a proteolytic f ...... ic and antitumorigenic factor.
@en
P2093
P2860
P921
P356
P1433
P1476
Vasculostatin, a proteolytic f ...... ic and antitumorigenic factor.
@en
P2093
Balveen Kaur
Daniel J Brat
Narra S Devi
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208317
P407
P577
2005-05-01T00:00:00Z
P5875
P6179
1024080673